The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Ltd

BSE 532872 · NSE SPARC · ISIN INE232I01014 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹194.75

+0.13%

BSE close, 28 August 2026

Market cap

₹6,320.06 cr

32.5 cr shares · Small cap

Free float

₹1,828.90 cr

as published

P/E · P/B

4.0× · -79.49×

EPS ₹48.79 · BV ₹-2.45

FY25-26 rev / PAT

1,879.17 / 1,552.13

₹ cr, as filed

Filings, window

10

2 selected · 20%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹108.20 52-WK HIGH ₹289.00 ₹194.75 48% of range
Against 52-week high-32.6%
Against 52-week low+80.0%
Day change+0.13%
Size bandSmall cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹48.79
Price / earnings3.99×
Price / book-79.49×
Book value — derived, price ÷ P/B₹-2.45
Return on equity-1,989.17%
Operating margin-26.68%
Net margin-52.56%

Consistency check

P/B ÷ P/E, which must equal ROE
-1,992.23%
ROE as published
-1,989.17%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 39.92 -20.98 -0.65 -26.68% -52.56%
Mar-26 · Q 1,853.22 1,760.70 54.26 95.77% 95.01%
FY25-26 1,879.17 1,552.13 47.83 84.95% 82.60%

Quarter on quarter

Revenue, quarter on quarter
-97.8%
Net profit, quarter on quarter
-101.2%
Operating margin, quarter on quarter
-12,245 bps

Disclosure profile 10 filings in the window

0 median 17.0 p75 · 25 sector max 52 10 16th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Results1
Selected sub-total2
Procedural
General2
AGM / EGM1
Board Meeting1
Compliance Certificate1
Monitoring Agency1
Newspaper Publication1
Trading Window1
Procedural sub-total8
Total10

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

10 filings · 2 selected · busiest 2026-08-10

Filing rhythm · the twelve most recent

2026-07-272026-10-07

SelectedProcedural

Filings

10 in the window · 11 earlier on record

  1. 7 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Confirmation Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 25 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation regarding Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 13 August 2026 ·

    General

    Filing Of Application For Reclassification With Stock Exchanges

    Filing of Application for Reclassification with Stock Exchanges

    Company Update / General View filing →

  4. 11 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisement for Publication of Financials

    Company Update / Newspaper Publication View filing →

  5. 10 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome of 21st Annual General Meeting of Sun Pharma Advanced Research Company Limited held on August 10, 2026

    AGM/EGM / AGM View filing →

  6. 10 August 2026 ·

    Monitoring Agency

    Monitoring Agency Report

    Monitoring Agency Report for the Quarter ended June 30, 2026

    Company Update / Monitoring Agency Report View filing →

  7. 10 August 2026 ·

    Results

    Unaudited Financial Results For The Quarter Ended June 30, 2026

    Financial Results

    Result / Financial Results View filing →

  8. 10 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting

    Outcome of the Board Meeting

    Board Meeting / Outcome of Board Meeting View filing →

  9. 3 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026

    Sun Pharma Advanced Research Company Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve unaudited ....

    Board Meeting / Board Meeting View filing →

  10. 27 July 2026 ·

    General

    Intimation For Receipt Of Requests For Reclassification Of Shareholder Category

    Intimation for Receipt of Request for Reclassification of Shareholder Category

    Company Update / General View filing →

RSS feed for Sun Pharma Advanced Research Company Ltd · the 50 most recent filings